Rejuvenate Bio: Funding, Investors & Team (Oct 2026)
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases. Founded on research from the Wyss Institute at Harvard Medical School, Rejuvenate Bio has developed innovative therapies aimed at addressing chronic age-related diseases in both humans and animals. The company has established a gene therapy pipeline with significant potential in treating chronic diseases. They leverage clinically validated gene targets and an effective delivery method to ensure long-lasting and well-tolerated gene expression.
Rejuvenate Bio has raised $6.0M across 1 funding round on record, the most recent an undisclosed round of $6.0M announced in Jun 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rejuvenate Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Rejuvenate Bio Funding Rounds
Rejuvenate Bio Founders and Leadership Team
No contact details are on record for this team yet.
Rejuvenate Bio Funding Compared to Other Biotechnology Startups
Rejuvenate Bio's latest round of $6.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rejuvenate Bio in Biotechnology and San Diego
Companies Similar to Rejuvenate Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Rejuvenate Bio Funding FAQs
What does Rejuvenate Bio do?
Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases. Founded on research from the Wyss Institute at Harvard Medical School, Rejuvenate Bio has developed innovative therapies aimed at addressing chronic age-related diseases in both humans and animals. The company has established a gene therapy pipeline with significant potential in treating chronic diseases. They leverage clinically validated gene targets and an effective delivery method to ensure long-lasting and well-tolerated gene expression.
How much funding has Rejuvenate Bio raised?
Rejuvenate Bio has raised $6.0M across 1 round on record. The most recent is an undisclosed round of $6.0M announced in Jun 2026.
When did Rejuvenate Bio last raise funding?
Rejuvenate Bio's most recent funding round on record is an undisclosed round of $6.0M, announced in Jun 2026.
Who founded Rejuvenate Bio?
FundedIQ lists Daniel Oliver (Founder) at Rejuvenate Bio.
Where is Rejuvenate Bio headquartered?
Rejuvenate Bio is based in San Diego, California, United States.
How many employees does Rejuvenate Bio have?
Rejuvenate Bio is in the 11-50 employee band.
How does Rejuvenate Bio's funding compare to other Biotechnology startups?
Rejuvenate Bio's latest round of $6.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Rejuvenate Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rejuvenate Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.